Reflux Disease in Head and Neck Cancer Patients Undergoing Radiation Therapy

NCT00928161 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Head and Neck Cancer
Oropharyngeal Cancer
Gastroesophageal Reflux Disease

Interventions

DRUG: Dexlansoprazole

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]